Chapter 46
description
Transcript of Chapter 46
![Page 1: Chapter 46](https://reader036.fdocuments.net/reader036/viewer/2022081519/56813b44550346895da41da8/html5/thumbnails/1.jpg)
Chapter 46
Care of Patients with Problems of the Peripheral Nervous System
Mrs. Marion Kreisel MSN, RNNU230 Adult Health 2Fall 2011
![Page 2: Chapter 46](https://reader036.fdocuments.net/reader036/viewer/2022081519/56813b44550346895da41da8/html5/thumbnails/2.jpg)
Guillain-Barré Syndrome
• Demyelination of the peripheral nerves, progressive motor weakness and sensory abnormalities
• Ascending paralysis• Result of a variety of related immune-
mediated pathologic processes
![Page 3: Chapter 46](https://reader036.fdocuments.net/reader036/viewer/2022081519/56813b44550346895da41da8/html5/thumbnails/3.jpg)
Clinical Manifestations• Muscle weakness and pain have abrupt
onset; cause remains obscure.• Cerebral function or pupillary signs are not
affected.• Cranial nerve involvement.• Autonomic dysfunction.• Weakness and paresthesia begin in the
lower extremities and progress upward toward the trunk, arms, and cranial nerves in ascending GBS.
![Page 4: Chapter 46](https://reader036.fdocuments.net/reader036/viewer/2022081519/56813b44550346895da41da8/html5/thumbnails/4.jpg)
Interventions
• Drug therapy• Plasmapheresis • Monitoring respiratory status and
managing the airway• Managing cardiac dysfunction• Improving mobility and preventing
complications of immobility• Managing pain• Promoting communication• Providing emotional support
![Page 5: Chapter 46](https://reader036.fdocuments.net/reader036/viewer/2022081519/56813b44550346895da41da8/html5/thumbnails/5.jpg)
Plasmapheresis
• Plasmapheresis removes the circulating antibodies assumed to cause the disease.
• Plasma is selectively separated from whole blood; the blood cells are returned to the patient without the plasma.
• Plasma usually replaces itself, or the patient is transfused with albumin.
![Page 6: Chapter 46](https://reader036.fdocuments.net/reader036/viewer/2022081519/56813b44550346895da41da8/html5/thumbnails/6.jpg)
Myasthenia Gravis
• Chronic disease characterized by weakness primarily in muscles innervated by cranial nerves, as well as in skeletal and respiratory muscles
• Thymoma—encapsulated thymus gland tumor
• Progressive paresis of affected muscle groups that is partially resolved by resting
• Most common symptoms—involvement of eye muscles, such as ocular palsies, ptosis, diplopia, weak or incomplete eye closure
![Page 7: Chapter 46](https://reader036.fdocuments.net/reader036/viewer/2022081519/56813b44550346895da41da8/html5/thumbnails/7.jpg)
Tensilon Testing
• Within 30 to 60 sec after injection of Tensilon, most myasthenic patients show marked improvement in muscle tone that lasts 4 to 5 minutes.
• Prostigmin is also used.• Cholinergic crisis is due to overmedication.• Myasthenic crisis is due to
undermedication.• Atropine sulfate is the antidote for Tensilon
complications.
![Page 8: Chapter 46](https://reader036.fdocuments.net/reader036/viewer/2022081519/56813b44550346895da41da8/html5/thumbnails/8.jpg)
Nonsurgical Management
• Respiratory support• Promoting mobility• Drug therapy:
• Cholinesterase inhibitor drugs• Immunosuppression• Plasmapheresis
![Page 9: Chapter 46](https://reader036.fdocuments.net/reader036/viewer/2022081519/56813b44550346895da41da8/html5/thumbnails/9.jpg)
Cholinesterase Inhibitor Drugs
• Drugs include anticholinesterase and antimyasthenics.
• Enhance neuromuscular impulse transmission by preventing decrease of ACh by the enzyme ChE.
• Administer with food.• Observe drug interactions.
![Page 10: Chapter 46](https://reader036.fdocuments.net/reader036/viewer/2022081519/56813b44550346895da41da8/html5/thumbnails/10.jpg)
Emergency Crises
• Myasthenic crisis—an exacerbation of the myasthenic symptoms caused by undermedication with anticholinesterases
• Cholinergic crisis—an acute exacerbation of muscle weakness caused by overmedication with cholinergic (anticholinesterase) drugs
![Page 11: Chapter 46](https://reader036.fdocuments.net/reader036/viewer/2022081519/56813b44550346895da41da8/html5/thumbnails/11.jpg)
Myasthenic Emergency Crisis
• Tensilon test is performed.• Priority for nursing management is to
maintain adequate respiratory function.• Cholinesterase-inhibiting drugs are
withheld because they increase respiratory secretions and are usually ineffective for the first few days after the crisis begins.
![Page 12: Chapter 46](https://reader036.fdocuments.net/reader036/viewer/2022081519/56813b44550346895da41da8/html5/thumbnails/12.jpg)
Cholinergic Emergency Crisis
• Anticholinergic drugs are withheld while the patient is maintained on a ventilator.
• Atropine may be given and repeated, if necessary.
• Observe for thickened secretions due to the drugs.
• Improvement is usually rapid after appropriate drugs have been given.
![Page 13: Chapter 46](https://reader036.fdocuments.net/reader036/viewer/2022081519/56813b44550346895da41da8/html5/thumbnails/13.jpg)
Management
• Immunosuppression• Plasmapheresis• Respiratory support• Promoting self-care guidelines• Assisting with communication• Nutritional support• Eye protection• Surgical management usually involving
thymectomy
![Page 14: Chapter 46](https://reader036.fdocuments.net/reader036/viewer/2022081519/56813b44550346895da41da8/html5/thumbnails/14.jpg)
Health Teaching
• Factors in exacerbation include infection, stress, surgery, hard physical exercise, sedatives, enemas, and strong cathartics.
• Avoid overheating, crowds, overeating, erratic changes in sleeping habits, and emotional extremes.
• Teach warning signs.• Teach importance of compliance.
![Page 15: Chapter 46](https://reader036.fdocuments.net/reader036/viewer/2022081519/56813b44550346895da41da8/html5/thumbnails/15.jpg)
Peripheral Nerve Trauma
• Vehicular or sports injury or wounds to the peripheral nerves
• Degeneration and retraction of the nerve distal to the injury within 24 hours
• Perioperative and postoperative care• Rehabilitation through physiotherapy
![Page 16: Chapter 46](https://reader036.fdocuments.net/reader036/viewer/2022081519/56813b44550346895da41da8/html5/thumbnails/16.jpg)
Peripheral Nerves
![Page 17: Chapter 46](https://reader036.fdocuments.net/reader036/viewer/2022081519/56813b44550346895da41da8/html5/thumbnails/17.jpg)
Peripheral Nerve Injury
![Page 18: Chapter 46](https://reader036.fdocuments.net/reader036/viewer/2022081519/56813b44550346895da41da8/html5/thumbnails/18.jpg)
Restless Legs Syndrome
• Leg paresthesias associated with an irresistible urge to move; commonly associated with peripheral and central nerve damage in the legs and spinal cord
• Management—symptomatic, involving treating the underlying cause or contributing factor, if known
• Nonmedical treatment• Drug therapy effective for some patients
![Page 19: Chapter 46](https://reader036.fdocuments.net/reader036/viewer/2022081519/56813b44550346895da41da8/html5/thumbnails/19.jpg)
Trigeminal Neuralgia
• Affects trigeminal or fifth cranial nerve• Nonsurgical management of facial pain—
drug therapy• Surgical management—microvascular
decompression, radiofrequency thermal coagulation, percutaneous balloon microcompression
• Postoperative care—monitoring for complications
• Characterized by intermittent episodes of severe pain with sudden onset
![Page 20: Chapter 46](https://reader036.fdocuments.net/reader036/viewer/2022081519/56813b44550346895da41da8/html5/thumbnails/20.jpg)
Trigeminal Nerve
![Page 21: Chapter 46](https://reader036.fdocuments.net/reader036/viewer/2022081519/56813b44550346895da41da8/html5/thumbnails/21.jpg)
Facial Paralysis or Bell’s Palsy
• Acute paralysis of seventh cranial nerve• Medical management—prednisone,
analgesics, acyclovir• Protection of the eye• Nutrition • Massage; warm, moist heat; facial
exercises• Pt education important: Usually symptoms
disappear or get better within a few weeks
![Page 22: Chapter 46](https://reader036.fdocuments.net/reader036/viewer/2022081519/56813b44550346895da41da8/html5/thumbnails/22.jpg)
NCLEX TIME
![Page 23: Chapter 46](https://reader036.fdocuments.net/reader036/viewer/2022081519/56813b44550346895da41da8/html5/thumbnails/23.jpg)
Question 1
Who is the typical patient who develops myasthenia gravis?
A. A man whose age of onset is between 60 and 70 years
B. A woman whose age of onset is between 20 and 30 years
C. A man whose age of onset is between 40 and 50 years
D. A woman whose age of onset is between 40 and 50 years
![Page 24: Chapter 46](https://reader036.fdocuments.net/reader036/viewer/2022081519/56813b44550346895da41da8/html5/thumbnails/24.jpg)
Question 2
Which assessment variable is the best early indicator of compromised neurovascular function?
A. Pallor B. Decreased pulses C. Tingling sensation D. Coolness of the extremity
![Page 25: Chapter 46](https://reader036.fdocuments.net/reader036/viewer/2022081519/56813b44550346895da41da8/html5/thumbnails/25.jpg)
Question 3
The effects of chemotherapy-induced peripheral neuropathy are expected to be:
A. Temporary and short-livedB. Dose-limiting and may cause permanent
disability C. Controlled with steroids such as
prednisone D. Not dose-limiting but may cause
temporary disability
![Page 26: Chapter 46](https://reader036.fdocuments.net/reader036/viewer/2022081519/56813b44550346895da41da8/html5/thumbnails/26.jpg)
Question 4
What conditions might the nurse expect to see in the patient with restless leg syndrome?
A. Diabetes and renal failureB. Peripheral vascular disease and multiple
sclerosis C. Myasthenia gravis and decreased visionD. Trigeminal neuralgia and facial paralysis
![Page 27: Chapter 46](https://reader036.fdocuments.net/reader036/viewer/2022081519/56813b44550346895da41da8/html5/thumbnails/27.jpg)
Question 5
A patient complains of eye dryness and acute pain of her face and behind her ear. The nurse should perform a focused assessment of which cranial nerve?
A. III B. V C. VIID. VIII